Cargando…
The activation of OR51E1 causes growth suppression of human prostate cancer cells
The development of prostate cancer (PCa) is regulated by the androgen-dependent activity of the androgen receptor (AR). Androgen-deprivation therapy (ADT) is therefore the gold standard treatment to suppress malignant progression of PCa. Nevertheless, due to the development of castration resistance,...
Autores principales: | Maßberg, Désirée, Jovancevic, Nikolina, Offermann, Anne, Simon, Annika, Baniahmad, Aria, Perner, Sven, Pungsrinont, Thanakorn, Luko, Katarina, Philippou, Stathis, Ubrig, Burkhard, Heiland, Markus, Weber, Lea, Altmüller, Janine, Becker, Christian, Gisselmann, Günter, Gelis, Lian, Hatt, Hanns |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217014/ https://www.ncbi.nlm.nih.gov/pubmed/27374083 http://dx.doi.org/10.18632/oncotarget.10197 |
Ejemplares similares
-
Olfactory Receptors as Biomarkers in Human Breast Carcinoma Tissues
por: Weber, Lea, et al.
Publicado: (2018) -
Odorant Receptor 51E2 Agonist β-ionone Regulates RPE Cell Migration and Proliferation
por: Jovancevic, Nikolina, et al.
Publicado: (2017) -
Deep Sequencing of the Human Retinae Reveals the Expression of Odorant Receptors
por: Jovancevic, Nikolina, et al.
Publicado: (2017) -
Characterization of the Olfactory Receptor OR10H1 in Human Urinary Bladder Cancer
por: Weber, Lea, et al.
Publicado: (2018) -
Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
por: Pungsrinont, Thanakorn, et al.
Publicado: (2021)